Emergency Use Authorization and COVID-19 Regulatory Support

The Alira Health Regulatory team has worked closely with our industry partners and the FDA during the COVID-19 pandemic, helping to bring critical products to market through the Emergency Use Authorization (EUA). The team, led by Mary McNamara-Cullinane, recently secured EUA approval for an innovative respiratory technology and has additional submissions currently in progress.

To learn more about how Alira Health can support your EUA submission, please contact Mary at mary.mcnamara@alirahealth.com